Learn more about how you can help build a more equitable system for all
From HIV to hepatitis C to COVID-19, financialization, patents, and structural racism have defined who gets access to life-saving medicines. GLP-1 drugs further expose this pattern—and point to a new path toward public, equitable models of medicine.
Learn more about how you can help build a more equitable system for all